Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • RNAddict
    Member
    • Mar 2012
    • 17

    Using NGS sequences before publishing

    I don't know if this has been encountered before (although it seems very likely) but I am wondering about the conventions or feelings people and editors have about using sequences generated from NGS before publishing a paper on your NGS?

    The lab I am did some RNAseq and assembled our transcript sequences. Great now I have a bunch of transcript sequences to work with (I am into cell bio and RNA bio more then bioinfromatics). We have pushed ahead with additional bioinfromatic analysis on your transcripts but are still a ways away from publishing the results of our NGS results.

    In the mean time I have also used some of the transcript sequences we assembled to do some actual wet lab experiments that are unrelated to our NGS project save for the fact that the sequences I used to construct primers act came from our RNAseq experiments.

    So essentially I would like to know if I have to wait for our NGS paper to be published and then cite that, or if I can reference the fact that we are currently engaged in RNAseq experiments and that this is where my transcript sequences came from.

    In the past my lab has used sequences from an EST library we have been constructing, but we never actually published on its construction. We would simply submit the sequences to NCBI whenever we used them in a publication.

    Have others run into this issue, what did you do? Anyone that serves as an editor or reviewer that has suggestions/comments?

    Thanks
    CC
  • GenoMax
    Senior Member
    • Feb 2008
    • 7142

    #2
    You could submit sequences from the contigs that you used in your study independently and get accession numbers for them.

    Comment

    • rskr
      Senior Member
      • Oct 2010
      • 249

      #3
      Merely sequencing data with standard protocols isn't often considered publication worthy, so the data tends to get published either with Informatics applications or Biological Analysis. However, to publish a novel sequencing approach before using the data to make some conclusions, might be a good idea.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 07-24-2026, 12:17 PM
      0 responses
      16 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-23-2026, 11:41 AM
      0 responses
      17 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-20-2026, 11:10 AM
      0 responses
      23 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-13-2026, 10:26 AM
      0 responses
      37 views
      0 reactions
      Last Post SEQadmin2  
      Working...